Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG Study
Marc Scherlinger(Université de Strasbourg), Renaud Felten(Centre National de la Recherche Scientifique), Jean Sibilia(Immunologie, Immunopathologie et Chimie Thérapeutique), Laurent Arnaud(Université Libre de Bruxelles), Jacques‐Eric Gottenberg(Centre National de la Recherche Scientifique), Emmanuel Chatelus(Laboratoire National de Référence), Luc Pijnenburg(Hôpitaux Universitaires de Strasbourg)
Cited by 47
Related Papers
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
|Seminars in Arthritis and Rheumatism|2007|456
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
|Annals of the Rheumatic Diseases|2016|355